1. Home
  2. ENTA vs TTSH Comparison

ENTA vs TTSH Comparison

Compare ENTA & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • TTSH
  • Stock Information
  • Founded
  • ENTA 1995
  • TTSH 1985
  • Country
  • ENTA United States
  • TTSH United States
  • Employees
  • ENTA N/A
  • TTSH N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • TTSH Blank Checks
  • Sector
  • ENTA Health Care
  • TTSH Finance
  • Exchange
  • ENTA Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • ENTA 316.2M
  • TTSH 279.3M
  • IPO Year
  • ENTA 2013
  • TTSH N/A
  • Fundamental
  • Price
  • ENTA $12.65
  • TTSH $6.34
  • Analyst Decision
  • ENTA Strong Buy
  • TTSH
  • Analyst Count
  • ENTA 6
  • TTSH 0
  • Target Price
  • ENTA $20.33
  • TTSH N/A
  • AVG Volume (30 Days)
  • ENTA 387.8K
  • TTSH 136.0K
  • Earning Date
  • ENTA 11-17-2025
  • TTSH 11-04-2025
  • Dividend Yield
  • ENTA N/A
  • TTSH N/A
  • EPS Growth
  • ENTA N/A
  • TTSH N/A
  • EPS
  • ENTA N/A
  • TTSH N/A
  • Revenue
  • ENTA $65,324,000.00
  • TTSH $338,787,000.00
  • Revenue This Year
  • ENTA $2.13
  • TTSH N/A
  • Revenue Next Year
  • ENTA $2.74
  • TTSH N/A
  • P/E Ratio
  • ENTA N/A
  • TTSH N/A
  • Revenue Growth
  • ENTA N/A
  • TTSH N/A
  • 52 Week Low
  • ENTA $4.09
  • TTSH $4.62
  • 52 Week High
  • ENTA $15.34
  • TTSH $7.75
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 66.08
  • TTSH 53.71
  • Support Level
  • ENTA $11.89
  • TTSH $6.28
  • Resistance Level
  • ENTA $13.00
  • TTSH $6.40
  • Average True Range (ATR)
  • ENTA 0.83
  • TTSH 0.09
  • MACD
  • ENTA 0.09
  • TTSH 0.00
  • Stochastic Oscillator
  • ENTA 80.78
  • TTSH 66.67

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: